Artificial Intelligence (AI)-Based Personalized Exercise Coaching for Patients With Breast Cancer
Effect of an Artificial Intelligence-Based Personalized Exercise Coaching System on Exercise Adherence and Quality of Life in Patients With Breast Cancer: A Randomized Controlled Trial
- Breast Cancer
At a glance
- Phase
- Phase not stated
- Study type
- Interventional
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Enrolment target
- 60
- Started
- 22 July 2026
- Main results due
- 22 March 2027
- Study sites
- 1
- Registry updated
- 28 September 2026
Can you take part?
- Ages 18 years to 70 years.
- Women only.
- You need the condition being studied — healthy volunteers are not accepted.
These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.
Read the full eligibility criteria
Inclusion Criteria: 1. Provision of written and dated informed consent. 2. Female participants aged 18 to 70 years. 3. Pathologically confirmed breast malignancy. 4. Completion of major cancer treatment, including surgery, chemotherapy, and/or radiotherapy, with clinically stable disease. 5. No severe cardiopulmonary dysfunction or contraindications to exercise. Exclusion Criteria: 1. Have not undergone breast cancer surgery. 2. Mental or psychological condition, as judged by the investigator, that would prevent adherence to the intervention or completion of follow-up.
What this study is about
In the sponsor’s own words, from the registry.
This prospective, single-center, randomized controlled trial aims to evaluate the effectiveness and safety of an artificial intelligence (AI)-based personalized exercise coaching system in female breast cancer survivors who have completed major cancer treatment and are clinically stable. A total of 100 eligible participants will be randomly assigned in a 1:1 ratio to either an AI-based exercise coaching group or a conventional exercise guidance group. Participants in the intervention group will receive personalized exercise recommendations generated by the AI exercise coaching system, with exercise data collected and used for dynamic adjustment of exercise guidance. Participants in the control group will receive conventional exercise recommendations provided by healthcare professionals. The intervention will last for 6 months. Exercise adherence will be evaluated as the primary outcome. Secondary outcomes will include quality of life, psychological status, physical function, exercise-related adverse events, and laboratory and metabolic parameters.
Study sites(1)
Ruijin Hospital
Shanghai, Shanghai Municipality, China
Recruiting
Showing 1 of 1 sites. 1 of the 1 site on this study is recruiting right now — a site can stop enrolling while the study as a whole is still open.
Source: ClinicalTrials.gov record NCT07844941. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.
Not the right study?
Answer three questions and see the studies recruiting near you, in plain language.
Find a study for me